Catawba Capital Management’s Merck MRK Stock Holding History

Catawba Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$3.82M	Buy	65,901 +4,611	+8%	+$260K	0.9%	41
2018 Q1	$3.19M	Sell	61,290 -173	-0.3%	-$9.34K	0.76%	48
2017 Q4	$3.3M	Sell	61,463 -477	-0.8%	-$26.4K	0.75%	48
2017 Q3	$3.78M	Sell	61,940 -37	-0.1%	-$2.24K	0.86%	44
2017 Q2	$3.79M	Buy	61,977 +3,471	+6%	+$211K	0.86%	41
2017 Q1	$3.55M	Buy	58,506 +860	+1%	+$52.2K	0.77%	42
2016 Q4	$3.24M	Buy	57,646 +1,190	+2%	+$69.6K	0.76%	46
2016 Q3	$3.36M	Sell	56,456 -4,145	-7%	-$242K	0.8%	44
2016 Q2	$3.33M	Buy	60,601 +1,314	+2%	+$69.9K	0.81%	45
2016 Q1	$2.99M	Buy	59,287 +8,635	+17%	+$423K	0.76%	46
2015 Q4	$2.55M	Sell	50,652 -1,859	-4%	-$93.7K	0.69%	50
2015 Q3	$2.48M	Buy	52,511 +3,487	+7%	+$185K	0.68%	52
2015 Q2	$2.66M	Buy	49,024 +508	+1%	+$28.5K	0.64%	54
2015 Q1	$2.66M	Buy	48,516 +3,818	+9%	+$216K	0.61%	54
2014 Q4	$2.42M	Sell	44,698 -1,598	-3%	-$89K	0.56%	63
2014 Q3	$2.62M	Hold	46,296	–	–	0.61%	62
2014 Q2	$2.56M	Sell	46,296 -33	-0.1%	-$1.8K	0.58%	66
2014 Q1	$2.51M	Sell	46,329 -697	-1%	-$36.1K	0.6%	64
2013 Q4	$2.25M	Buy	47,026 +1,027	+2%	+$46.9K	0.54%	68
2013 Q3	$2.09M	Buy	45,999 +1,343	+3%	+$61.3K	0.55%	66
2013 Q2	$1.98M	Buy	+44,656	New	+$1.99M	0.55%	66

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Catawba Capital Management's MRK Position: Q2 2018 in Review

Catawba Capital Management increased its Merck (MRK) stake by 7.5% in Q2 2018, buying an estimated $260K and bringing the position to 65,901 shares worth $3.82M. The position accounts for 0.9% of the portfolio, ranked #41.

Catawba Capital Management first reported a position in MRK in Q2 2013 and has held it in 21 quarters since. 2,017 funds tracked by Wall St. Rank hold MRK as of Q2 2018.

Catawba Capital Management held 65,901 shares of Merck worth $3.82M as of Q2 2018.
Catawba Capital Management bought 4,611 Merck shares in Q2 2018, an estimated $260K.
Merck made up 0.9% of Catawba Capital Management's portfolio in Q2 2018, its #41 holding.
Catawba Capital Management first reported a position in Merck in Q2 2013 and has held it in 21 quarters since.
2,017 funds tracked by Wall St. Rank held Merck as of Q2 2018.

Based on Catawba Capital Management's 13F filing for Q2 2018, filed 11 Jul 2018.